Apex Biotechnology (TPE:1733) Long-Term Capital Lease Obligation : NT$116 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Long-Term Capital Lease Obligation?

Apex Biotechnology's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$116 Mil.

Apex Biotechnology's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (NT$118 Mil) to Dec. 2023 (NT$116 Mil) and declined from Dec. 2023 (NT$116 Mil) to Mar. 2024 (NT$116 Mil).

Apex Biotechnology's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (NT$128 Mil) to Dec. 2022 (NT$123 Mil) and declined from Dec. 2022 (NT$123 Mil) to Dec. 2023 (NT$116 Mil).

Apex Biotechnology Long-Term Capital Lease Obligation Historical Data

The historical data trend for Apex Biotechnology's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Long-Term Capital Lease Obligation Chart

Apex Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

122.48

118.28

127.66

122.67

116.20

Apex Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															120.34	118.88	118.03	116.20	115.83

Apex Biotechnology (TPE:1733) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Apex Biotechnology Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology (TPE:1733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines